{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:32:24Z","timestamp":1792197144905,"version":"4.4.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900294"],"award-info":[{"award-number":["81900294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of this study was to examine the utility of liver function tests (LFTs) in predicting the prognosis of critically ill patients with primary pulmonary hypertension (PPH) with\/without liver disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrieved the Medical Information Mart for Intensive Care III (MIMIC-III) database to acquire clinical data. From the database, we recruited adult patients that were equal to or older than 18 years with primary pulmonary hypertension (PPH) discharge from intensive care unit (ICU). Then, the relationship between LFTs and duration of hospitalization and ICU stays was examined based on the Spearman correlation. The chi-square assessment was conducted to examine the correlation between LFTs and death rates. Survival curves were plotted with the aid of the Kaplan-Meier technique, and the curves were subsequently compared utilizing the log-rank test. The LFTs were identified as independent predictive variables of death according to the results of multivariable logistic regression. The specificity and sensitivity for mortality were calculated utilizing receiver operating characteristic (ROC) curves and the area under the curve (AUC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 198 patients satisfying the inclusion criteria were recruited, among which there were 23 patients with liver disease. Only ALB was correlated with the length of ICU stay in the total PPH group. ALB independently served as a risk variable for hospital mortality and 90-day mortality and was significantly associated with 90-day and 4-year survival rates in both total PPH and PPH without liver disease. AST was correlated with hospital mortality and 90-day survival curves in both total PPH and PPH without liver disease and independently served as a risk factor for hospital and 90-day mortality only in the total PPH group. ALT independently acted as a risk variable for hospital mortality and total bilirubin was correlated with hospital mortality in the total group. The diagnostic performance of the predictive model combining the LFTs was moderately good for the hospital, 90-day, and 4-year mortality. Both Model\u0131 End-Stage \u0131Liver\u0131 Disease (MELD) score and albumin-bilirubin (ALBI) score were independent risk factors for short- and long-term prognosis. And they were also significantly associated with short- and long-term prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among critically ill patients with PPH and with or without liver illness, aberrant LFT was linked to short- and long-term prognoses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.897040","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:51:37Z","timestamp":1654149097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"Dayu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/s0140-6736(84)91452-1","article-title":"Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).","volume":"1","author":"Higenbottam","year":"1984","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1164\/rccm.201903-0656CI","article-title":"Beyond the lungs: systemic manifestations of pulmonary arterial hypertension.","volume":"201","author":"Nickel","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure.","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"crossref","first-page":"20458940211054304","DOI":"10.1177\/20458940211054304","article-title":"Liver abnormalities in pulmonary arterial hypertension.","volume":"11","author":"Nickel","year":"2021","journal-title":"Pulm Circ."},{"key":"B5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension.","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/clc.22954","article-title":"Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension.","volume":"41","author":"Snipelisky","year":"2018","journal-title":"Clin Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0193245","DOI":"10.1371\/journal.pone.0193245","article-title":"Predictors of poor outcome in patients with pulmonary arterial hypertension: a single center study.","volume":"13","author":"Stepnowska","year":"2018","journal-title":"PLoS One."},{"key":"B9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","article-title":"Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.","volume":"30","author":"Benza","year":"2011","journal-title":"J Heart Lung Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3892\/etm.2015.2376","article-title":"High levels of serum lactate dehydrogenase correlate with the severity and mortality of idiopathic pulmonary arterial hypertension.","volume":"9","author":"Hu","year":"2015","journal-title":"Exp Ther Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","article-title":"MIMIC-III, a freely accessible critical care database.","volume":"3","author":"Johnson","year":"2016","journal-title":"Sci Data."},{"key":"B12","doi-asserted-by":"publisher","first-page":"724179","DOI":"10.3389\/fcvm.2021.724179","article-title":"Novel prognostic predictor for primary pulmonary hypertension: focus on blood urea nitrogen.","volume":"8","author":"Hu","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","article-title":"The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.","volume":"66","author":"Pinato","year":"2017","journal-title":"J Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/lt.20260","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.","volume":"10","author":"Mandell","year":"2004","journal-title":"Liver Transpl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MOG.0000000000000355","article-title":"Current concepts in ischemic hepatitis.","volume":"33","author":"Lightsey","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy.","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1016\/j.bbagen.2013.04.012","article-title":"Novel insights into the pleiotropic effects of human serum albumin in health and disease.","volume":"1830","author":"Ha","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cardfail.2011.02.010","article-title":"Human serum albumin in the clinical syndrome of heart failure.","volume":"17","author":"Arques","year":"2011","journal-title":"J Card Fail."},{"key":"B20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition.","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial."},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1054\/clnu.2001.0439","article-title":"Causes and mechanisms of hypoalbuminaemia.","volume":"20","author":"Ballmer","year":"2001","journal-title":"Clin Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCHEARTFAILURE.110.949933","article-title":"Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension.","volume":"4","author":"Haddad","year":"2011","journal-title":"Circ Heart Fail."},{"key":"B23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients.","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications.","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijcard.2007.07.094","article-title":"Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study.","volume":"125","author":"Arques","year":"2008","journal-title":"Int J Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL).","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijcard.2016.11.036","article-title":"Direct bilirubin: a new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.","volume":"228","author":"Xu","year":"2017","journal-title":"Int J Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients.","volume":"44","author":"Hao","year":"2014","journal-title":"Eur Respir J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2466-10-22","article-title":"Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension.","volume":"10","author":"Takeda","year":"2010","journal-title":"BMC Pulm Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.897040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:51:44Z","timestamp":1654149104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.897040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2022.897040"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.897040","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"897040"}}